Kern Capital, LLC — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
GPN VaccinesJun 2024 · $18M
BiotechWilmington, US
Timothy Hirst(Executive Officer, Director)James Selkirk(Executive Officer)in
Co-investorsForepont Capital PartnersShearwater Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.